BIOX (Bioceres Crop Solutions Corp.) Stock Financials & Earnings

BIOXBioceres Crop Solutions Corp.

Mkt Cap$34M

Revenue (TTM)$318M

Net Income (TTM)-$53M

EPS (TTM)-$0.84

Free Cash Flow (TTM)$37M

Gross Margin39.1%

Op. Margin0.2%

Net Margin-16.6%

FCF Margin11.5%

P/S Ratio (TTM)0.1x

P/E Ratio (TTM)—

YoY Rev Growth-27.9%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q2 23	$95M	$34M	$2M
Q3 23	$93M	$56M	$30M
Q4 23	$105M	$39M	$5M
Q1 24	$116M	$44M	$5M
Q2 24	$140M	$52M	$17M
Q3 24	$84M	$43M	$13M
Q4 24	$124M	$42M	$9M
Q1 25	$93M	$37M	$2M
Q2 25	$107M	$45M	$8M
Q3 25	$60M	$23M	$933K
Q4 25	$74M	$24M	-$15M
Q1 26	$77M	$32M	$7M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q2 23	$3M	$27M	$1M
Q3 23	$4M	$23M	$1M
Q4 23	$4M	$1M	$1M
Q1 24	$5M	$22M	$5M
Q2 24	$4M	$34M	$1M
Q3 24	$4M	$30M	$1M
Q4 24	$5M	$19M	$4M
Q1 25	—	$17M	$1M
Q2 25	—	$28M	$850K
Q3 25	$4M	$17M	$4M
Q4 25	—	$18M	$4M
Q1 26	$6M	$14M	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 23	$69M	$19M	$87M
Q3 23	$58M	$13M	$71M
Q4 23	$48M	$12M	$60M
Q1 24	$28M	$15M	$43M
Q2 24	$24M	$17M	$41M
Q3 24	$16M	$16M	$33M
Q4 24	$44M	$12M	$56M
Q1 25	$32M	$6M	$38M
Q2 25	$29M	$2M	$31M
Q3 25	$38M	$889K	$39M
Q4 25	$33M	$2M	$35M
Q1 26	$16M	$1M	$17M

Shares Outstanding

Revenue Per Employee

Revenue / Employee